The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Bisoprolol Fumarate (NDC 70771-1726). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
NDC 70771-1726-3
Bisoprolol Fumarate Tablets USP, 5 mg
30 Tablets
Unit-of-Use
Rx only
5 mg Label (E6a69c5b Fe95 45b3 895f 259e4b49f6c5 01)
NDC 70771-1727-3
Bisoprolol Fumarate Tablets USP, 10 mg
30 Tablets
Unit-of-Use
Rx only
10 mg Label (E6a69c5b Fe95 45b3 895f 259e4b49f6c5 02)
* Please review the disclaimer below.
